The Kid-Short Marfan Score (Kid-SMS) - An easy executable risk score for suspected paediatric patients with Marfan syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 2, 2013, Pages

  Mueller, Goetz C ^a   Stark, Veronika ^a   Steiner, Kristoffer ^a   Weil, Jochen ^a   Von Kodolitsch, Yskert ^a   Mir, Thomas S ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Cardiovascular symptoms; Children; Marfan; Risk score

Indexed keywords

ADOLESCENT; AORTA DISEASE; AORTIC ROOT DILATION; ARTERY DISEASE; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE CLASSIFICATION; ECTOPIA LENTIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; KID SHORT MARFAN SCORE; KYPHOSIS; LUNG ARTERY DILATATION; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MYOPIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SCOLIOSIS; SCORING SYSTEM; THORAX DEFORMITY; VALVULAR HEART DISEASE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MALE; MARFAN SYNDROME; RISK ASSESSMENT;

EID: 84872300366     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12072     Document Type: Article

References (27)

1. Dean JC,. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 2007; 15: 724-33.
2. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-9.
3. Judge DP, Dietz HC,. Marfan's syndrome. Lancet 2005; 366: 1965-76.
4. von Kodolitsch Y, Rybczynski M, Detter C, Robinson PN,. Diagnosis and management of Marfan syndrome. Future Cardiol 2008; 4: 85-96.
5. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE,. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-26.
6. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-85.
7. Faivre L, Collod-Beroud G, Ades L, Arbustini E, Child A, Callewaert BL, et al. The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet 2012; 81: 433-42.
8. Lipscomb KJ, Clayton-Smith J, Harris R,. Evolving phenotype of Marfan's syndrome. Arch Dis Child 1997; 76: 41-6.
9. Stuart AG, Williams A,. Marfan's syndrome and the heart. Arch Dis Child 2007; 92: 351-6.
10. Knirsch W, Hillebrand D, Horke A, Lewin MA, Rein J, Uhlemann F,. Aortic aneurysm rupture in infantile Marfan's syndrome. Pediatr Cardiol 2001; 22: 156-9.
11. Rybczynski M, Bernhardt AM, Rehder U, Fuisting B, Meiss L, Voss U, et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A 2008; 146A: 3157-66.
12. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002; 40: 1298-304.
13. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
14. Avierinos JF, Detaint D, Messika-Zeitoun D, Mohty D, Enriquez-Sarano M,. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am J Cardiol 2008; 101: 662-7.
15. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J,. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507-12.
16. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000; 83: 667-72.
17. Miyatake K, Izumi S, Okamoto M, Kinoshita N, Asonuma H, Nakagawa H, et al. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986; 7: 82-8.
18. Oosterhof T, Groenink M, Hulsmans FJ, Mulder BJ, van der Wall EE, Smit R, et al. Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology 2001; 220: 514-8.
19. Habermann CR, Weiss F, Schoder V, Cramer MC, Kemper J, Wittkugel O, et al. MR evaluation of dural ectasia in Marfan syndrome: reassessment of the established criteria in children, adolescents, and young adults. Radiology 2005; 234: 535-41.
20. Faivre L, Masurel-Paulet A, Collod-Beroud G, Callewaert BL, Child AH, Stheneur C, et al. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics 2009; 123: 391-8.
21. Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81: 454-66.
22. van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M,. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001; 84: 129-37.
23. Sisk HE, Zahka KG, Pyeritz RE,. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol 1983; 52: 353-8.
24. Rybczynski M, Mir TS, Sheikhzadeh S, Bernhardt AM, Schad C, Treede H, et al. Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol 2010; 106: 1048-53.
25. Okura H, Takada Y, Yamabe A, Ozaki T, Yamagishi H, Toda I, et al. Prevalence and correlates of physiological valvular regurgitation in healthy subjects. Circ J 2011; 75: 2699-704.
26. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121: e266-369.
27. Stheneur C, Faivre L, Collod-Beroud G, Gautier E, Binquet C, Bonithon-Kopp C, et al. Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res 2011; 69: 265-70.